We are live on ! Find out more
DCPH

Deciphera Pharmaceuticals, Inc. Common Stock
DCPH

Delisted

DCPH was delisted on the 10th of June, 2024.

Back to rankings

1 hedge funds and large institutions have $759K invested in Deciphera Pharmaceuticals, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 174 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 177 → 1 (-176)

100% less capital invested

Capital invested by funds: $944M → $759K (-$943M)

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 174

Holders
1
Holders Change
-176
Holders Change %
-99.44%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
174
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$94.3M
2
AC
Armistice Capital
New York
-$92.8M
3
RG
Redmile Group
California
-$83.3M
4
DM
Deerfield Management
New York
-$80.7M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$71.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
– -$8.12M -515,955 Closed
D.E. Shaw & Co
27
D.E. Shaw & Co
New York
– -$7.97M -506,384 Closed
Deutsche Bank
28
Deutsche Bank
Germany
– -$7.67M -487,360 Closed
Jacobs Levy Equity Management
29
Jacobs Levy Equity Management
New Jersey
– -$7.42M -471,977 Closed
PAM
30
Panagora Asset Management
Massachusetts
– -$6.56M -417,064 Closed
Two Sigma Advisers
31
Two Sigma Advisers
New York
– -$6.31M -401,200 Closed
UBS AM
32
UBS AM
Illinois
– -$6.27M -398,540 Closed
SSA
33
Schonfeld Strategic Advisors
New York
– -$5.65M -359,267 Closed
Norges Bank
34
Norges Bank
Norway
– -$5.54M -352,000 Closed
Two Sigma Investments
35
Two Sigma Investments
New York
– -$4.91M -312,426 Closed
Walleye Capital
36
Walleye Capital
New York
– -$4.63M -294,229 Closed
EIM
37
Essex Investment Management
Massachusetts
– -$4.54M -288,635 Closed
Connor, Clark & Lunn Investment Management (CC&L)
38
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
– -$4.39M -279,047 Closed
LCM
39
Laurion Capital Management
New York
– -$4.32M -274,634 Closed
CSS
40
Cubist Systematic Strategies
Connecticut
– -$3.95M -250,889 Closed
Qube Research & Technologies (QRT)
41
Qube Research & Technologies (QRT)
United Kingdom
– -$3.81M -242,056 Closed
Bank of America
42
Bank of America
North Carolina
– -$3.51M -223,187 Closed
Rafferty Asset Management
43
Rafferty Asset Management
New York
– -$3.43M -218,237 Closed
Public Sector Pension Investment Board (PSP Investments)
44
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
– -$3.37M -214,000 Closed
Citigroup
45
Citigroup
New York
– -$3.02M -191,849 Closed
Bank of New York Mellon
46
Bank of New York Mellon
New York
– -$3.01M -191,432 Closed
Voloridge Investment Management
47
Voloridge Investment Management
Florida
– -$2.86M -182,059 Closed
GTC
48
Ghost Tree Capital
New York
– -$2.78M -176,513 Closed
UBS Group
49
UBS Group
Switzerland
– -$2.62M -166,438 Closed
ECM
50
ExodusPoint Capital Management
New York
– -$2.53M -160,690 Closed
1
2
3 4 5

DCPH Hedge Fund Activity: Q2 2024 in Review

1 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) for Q2 2024, worth a combined $759K — down 100% from $944M a quarter earlier.

Sellers outnumbered buyers: 174 funds closed out of DCPH and 0 opened new positions — a net loss of 174 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $94.3M sold.

  • 1 institutional investor held Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) as of Q2 2024, down from 177 in Q1 2024.
  • Funds reported $759K of Deciphera Pharmaceuticals, Inc. Common Stock stock for Q2 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Deciphera Pharmaceuticals, Inc. Common Stock positions in Q2 2024 and 174 closed out, a net change of -174 holders.
  • The largest Deciphera Pharmaceuticals, Inc. Common Stock seller in Q2 2024 was BlackRock, an estimated $94.3M sold.

Based on aggregated 13F filings for Q2 2024.